| Literature DB >> 31727948 |
Matías Gutiérrez-González1,2, Camila Farías1, Samantha Tello1, Diana Pérez-Etcheverry3, Alfonso Romero1, Roberto Zúñiga1, Carolina H Ribeiro1, Carmen Lorenzo-Ferreiro3, María Carmen Molina4.
Abstract
Recombinant protein expression for structural and therapeutic applications requires the use of systems with high expression yields. Escherichia coli is considered the workhorse for this purpose, given its fast growth rate and feasible manipulation. However, bacterial inclusion body formation remains a challenge for further protein purification. We analyzed and optimized the expression conditions for three different proteins: an anti-MICA scFv, MICA, and p19 subunit of IL-23. We used a response surface methodology based on a three-level Box-Behnken design, which included three factors: post-induction temperature, post-induction time and IPTG concentration. Comparing this information with soluble protein data in a principal component analysis revealed that insoluble and soluble proteins have different optimal conditions for post-induction temperature, post-induction time, IPTG concentration and in amino acid sequence features. Finally, we optimized the refolding conditions of the least expressed protein, anti-MICA scFv, using a fast dilution protocol with different additives, obtaining soluble and active scFv for binding assays. These results allowed us to obtain higher yields of proteins expressed in inclusion bodies. Further studies using the system proposed in this study may lead to the identification of optimal environmental factors for a given protein sequence, favoring the acceleration of bioprocess development and structural studies.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31727948 PMCID: PMC6856375 DOI: 10.1038/s41598-019-53200-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1anti-MICA scFv, MICA , and IL-23-p19 are expressed in inclusion bodies in E. coli BL21. Samples from different culture steps were separated by SDS-PAGE (left), and analyzed by western blot (right) using an anti-His antibody. (a) anti-MICA scFv. (b) MICA. (c) IL-23p19. Molecular weights are indicated in kDa. 1: Protein ladder. 2: Total bacterial lysate after induction. 3: Soluble fraction of lysate. 4: Insoluble fraction of lysate. 5: Flow through of chromatographic purifications. 6: Elution. For C: 1: Protein ladder. 2: Total bacterial lysate before induction. 3: Total bacterial lysate after induction. 4: Soluble fraction of lysate. 5: Soluble fraction after incubation with Triton X-100. 6: Soluble fraction after treatement with N-Lauroylsarcosine. 7: Flow through of chromatographic purifications. 8: Elution. The bands of expected size were analyzed by mass spectrometry (MALDI-TOF/TOF 4800 Analyzer, Applied Biosystems, Framingham, USA) confirming the identity of interleukin-23 subunit alpha precursor Homo sapiens (data not shown).
Box-Behnken design.
| Variable | Level | ||
|---|---|---|---|
| Coded values | −1 | 0 | +1 |
| A: Temperature (°C) | 25 | 31 | 37 |
| B: Time (h) | 3 | 4,5 | 6 |
| C: IPTG (mM) | 0.1 (MICA, scFv), 0.2 (IL-23p19) | 0.55 (MICA, scFv), 0.6 (IL-23p19) | 1 |
Coded and actual variables are shown. For time and IPTG, information shown is for MICA, anti-MICA scFv (left) and IL-23p19 (right).
Experimental runs for Box-Behnken design.
| Run | Coded | Actual | Yield (mg/mL) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| A | B | C | Temperature (°C) | Time (h) | IPTG (mM) | MICA | anti-MICA scFv | IL-23p19 | |
| 1 | −1 | −1 | 0 | 25 | 3 | 0.55/0.6 | 0.068 | 0.11 | 1.8 |
| 2 | 1 | −1 | 0 | 37 | 3 | 0.55/0.6 | 0.285 | 0.094 | 5.1 |
| 3 | −1 | 1 | 0 | 25 | 6/5 | 0.55/0.6 | 0.249 | 0.177 | 1 |
| 4 | 1 | 1 | 0 | 37 | 6/4 | 0.55/0.6 | 0.633 | 0.067 | 2.8 |
| 5 | −1 | 0 | −1 | 25 | 4.5/4 | 0.1/0.2 | 0.311 | 0.077 | 2.2 |
| 6 | 1 | 0 | −1 | 37 | 4.5/4 | 0.1/0.2 | 0.563 | 0.085 | 4.2 |
| 7 | −1 | 0 | 1 | 25 | 4.5/4 | 1 | 0.103 | 0.133 | 2 |
| 8 | 1 | 0 | 1 | 37 | 4.5/4 | 1 | 0.415 | 0.068 | 3.9 |
| 9 | 0 | −1 | −1 | 31 | 3 | 0.1/0.2 | 0.249 | 0.083 | 2.1 |
| 10 | 0 | 1 | −1 | 31 | 6/5 | 0.1/0.2 | 0.426 | 0.133 | 1 |
| 11 | 0 | −1 | 1 | 31 | 3 | 1 | 0.248 | 0.123 | 2.8 |
| 12 | 0 | 1 | 1 | 31 | 6/5 | 1 | 0.237 | 0.147 | 1 |
| 13 | 0 | 0 | 0 | 31 | 4.5/4 | 0.55/0.6 | 0.221 | 0.154 | 2.5 |
| 14 | 0 | 0 | 0 | 31 | 4.5/4 | 0.55/0.6 | 0.339 | 0.164 | 2.7 |
| 15 | 0 | 0 | 0 | 31 | 4.5/4 | 0.55/0.6 | 0.317 | 0.220 | 2.3 |
Coded and actual variables are shown. For time and IPTG, information shown is for MICA, anti-MICA scFv (left) and IL-23p19 (right).
Figure 2Surface response plots of expressed proteins. The effect of post-induction temperature, post-induction time and IPTG concentration on the expression of MICA (a), anti-MICA scFv (b) and IL-23p19 (c) is shown.
Literature search of proteins optimized by a DoE approach.
| Protein | Hosts tested | Expression vector | Tag | Design Type | Significance (p < 0.05) | Optimal value | Host | Type | Reference | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Temp | Time | IPTG | Temp | Time | IPTG | ||||||||
| NS3 1b L13K | BL21(DE3) BL21(DE3)pLys | pBEV11 | His | Full Factorial and Box-Behnken | Yes | No | No | 21 | 18 | 0.55 | BL21(DE3) | Soluble | Swalley SE |
| PsaA | BL21(DE3) Star | pET28a | No Tag | CCD | Yes | Yes | No | 25 | 16 | 0.1 | BL21(DE3) Star | Soluble | Larentis AL |
| TNFa | BL21(DE3), BL21(DE3)pLys Rosetta | pGEX | GST | CCD | Yes | Yes | No | 25 | 4 | 1 | BL21(DE3)pLys | Soluble | Papaneophytou CP and Kontopidis GA, 2012 |
| RANKL | BL21(DE3), BL21(DE3)pLys Rosetta | pGEX-6P-1 | GST | CCD | Yes | Yes | Yes | 25 | 6.5 | 0.3 | BL21(DE3)pLys | Soluble | Papaneophytou CP |
| HO-1 | BL21(DE3) Rosetta | pET28a | His | CCD | Yes | Yes | Yes | 22 | 24 | 0.25 | Rosetta | Soluble | Papaneophytou CP and Kontopidis GA, 2016 |
| Ply | BL21(DE3) Star | pET28a | No Tag | Fractional Factorial | Yes | No | Yes | 25 | 4 | 0.1 | BL21(DE3) Star | Soluble | Marini G |
| LigB | BL21(DE3) Star | pAE | His | CCD | No | No | Yes | 28 | 4 | 0.1 | BL21(DE3) Star | Soluble | Larentis AL |
| Luciferase | BL21(DE3) | pET30a | No Tag | CCF | Yes | Yes | Yes | 30 | 18 | 0.5 | BL21(DE3) | Soluble | Islam RS |
| β-NG | BL21(DE3) | pET39b(+) | DsbA signal, His (Nterm and Cterm), S-Tag (Cterm) | CCD | Yes | Yes | Yes | 25 | 2 | 1 | BL21(DE3) | Soluble | Tilko P |
| non-specific nuclease | BL21, BL21 (DE3)pLysS StarTM (DE3)plysS | pET-24a and pET-24d | His | CCD | Yes | Yes | Yes | 32 | 20.5 | 1.5 | BL 21 StarTM (DE3)plysS | Soluble | Fang XJ |
Figure 3Principal component analysis (PCA) calculated from environmental (a,b) and sequence-derived features (c,d) for soluble and insoluble proteins. (a) PCA from environmental variables showing concentration ellipses for soluble and insoluble proteins at 95% confidence. (b) Correlation plot of variables used in (a). (c) PCA from sequence-derived features showing concentration ellipses for soluble and insoluble proteins at 95% confidence. (d) Correlation plot of variables used in (c). KmR: Lysine minus arginine ; DpE: Aspartic acid plus glutamic acid; PpN: Lysine plus arginine plus aspartic acid plus glutamic acid. Both analysis were performed on R using FactoMineR package.
Figure 4anti-MICA scFv renaturation experiments. (a) Ten microliters of purified anti-MICA scFv, in denaturing conditions, was fast-diluted in 200 µL of different refolding buffers. (b) The binding ability of purified and refolded anti-MICA scFv, in three different buffers, was analyzed by ELISA at two concentrations. Buffer 1: 50 mM Tris HCl, pH 7.4. Buffer 2: Buffer 1 + 500 mM NaCl. Buffer 3: Buffer 1 + 500 mM arginine. Buffer 4: Buffer 1 + 10% glycerol. Buffer 5: Buffer 1 + GSH/GSSG (10:1). Buffer 6: Buffer 2 + GSH/GSSG (10:1). Buffer 7: Buffer 3 + GSH/GSSG (10:1). Buffer 8: Buffer 4 + GSH/GSSG (10:1).